The Economist (Sept 2, 2010) estimated that the counterfeit drug market is worth approximately $75-billion a year. Of all medicines sold worldwide, some 15 percent are counterfeit. In developing countries, counterfeit drugs amount to approximately 30 percent of drugs sold. In May 2010, the Sixty-Third World Health Assembly (WHA...
Executive Board Meeting, 130th session, January 16-23, 2012
The Executive Board Meeting is important in the lead-up to the World Health Assembly (WHA). The Executive Board is composed of 34 members, each appointed by a Member State and elected by the WHA. The members of the Board are individuals with technical expertise in the field of health, and...
The World Health Organization (WHO) is embarking on the most extensive administrative, managerial, and financial reforms in its 63-year history. While reform discussions started in 2010 under the title “Future Financing for the WHO,” they now encompass an organization-wide reform. The debate has expanded to include questions around the WHO’s...



